206 related articles for article (PubMed ID: 31519704)
1. GATA3-Controlled Nucleosome Eviction Drives
Belver L; Yang AY; Albero R; Herranz D; Brundu FG; Quinn SA; Pérez-Durán P; Álvarez S; Gianni F; Rashkovan M; Gurung D; Rocha PP; Raviram R; Reglero C; Cortés JR; Cooke AJ; Wendorff AA; Cordó V; Meijerink JP; Rabadan R; Ferrando AA
Cancer Discov; 2019 Dec; 9(12):1774-1791. PubMed ID: 31519704
[TBL] [Abstract][Full Text] [Related]
2. Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c-myc.
Sharma VM; Calvo JA; Draheim KM; Cunningham LA; Hermance N; Beverly L; Krishnamoorthy V; Bhasin M; Capobianco AJ; Kelliher MA
Mol Cell Biol; 2006 Nov; 26(21):8022-31. PubMed ID: 16954387
[TBL] [Abstract][Full Text] [Related]
3. A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia.
Herranz D; Ambesi-Impiombato A; Palomero T; Schnell SA; Belver L; Wendorff AA; Xu L; Castillo-Martin M; Llobet-Navás D; Cordon-Cardo C; Clappier E; Soulier J; Ferrando AA
Nat Med; 2014 Oct; 20(10):1130-7. PubMed ID: 25194570
[TBL] [Abstract][Full Text] [Related]
4. Cooperation of Gata3, c-Myc and Notch in malignant transformation of double positive thymocytes.
van Hamburg JP; de Bruijn MJ; Dingjan GM; Beverloo HB; Diepstraten H; Ling KW; Hendriks RW
Mol Immunol; 2008 Jun; 45(11):3085-95. PubMed ID: 18471881
[TBL] [Abstract][Full Text] [Related]
5. T-ALL pathogenesis requires a NOTCH1-driven MYC enhancer.
Cancer Discov; 2014 Nov; 4(11):OF17. PubMed ID: 25367958
[TBL] [Abstract][Full Text] [Related]
6. Long-range enhancer activity determines Myc sensitivity to Notch inhibitors in T cell leukemia.
Yashiro-Ohtani Y; Wang H; Zang C; Arnett KL; Bailis W; Ho Y; Knoechel B; Lanauze C; Louis L; Forsyth KS; Chen S; Chung Y; Schug J; Blobel GA; Liebhaber SA; Bernstein BE; Blacklow SC; Liu XS; Aster JC; Pear WS
Proc Natl Acad Sci U S A; 2014 Nov; 111(46):E4946-53. PubMed ID: 25369933
[TBL] [Abstract][Full Text] [Related]
7. RUNX1 is required for oncogenic
Choi A; Illendula A; Pulikkan JA; Roderick JE; Tesell J; Yu J; Hermance N; Zhu LJ; Castilla LH; Bushweller JH; Kelliher MA
Blood; 2017 Oct; 130(15):1722-1733. PubMed ID: 28790107
[TBL] [Abstract][Full Text] [Related]
8. The Notch1/c-Myc pathway in T cell leukemia.
Sharma VM; Draheim KM; Kelliher MA
Cell Cycle; 2007 Apr; 6(8):927-30. PubMed ID: 17404512
[TBL] [Abstract][Full Text] [Related]
9. Stage-specific roles for Zmiz1 in Notch-dependent steps of early T-cell development.
Wang Q; Yan R; Pinnell N; McCarter AC; Oh Y; Liu Y; Sha C; Garber NF; Chen Y; Wu Q; Ku CJ; Tran I; Serna Alarcon A; Kuick R; Engel JD; Maillard I; Cierpicki T; Chiang MY
Blood; 2018 Sep; 132(12):1279-1292. PubMed ID: 30076146
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide analysis reveals conserved and divergent features of Notch1/RBPJ binding in human and murine T-lymphoblastic leukemia cells.
Wang H; Zou J; Zhao B; Johannsen E; Ashworth T; Wong H; Pear WS; Schug J; Blacklow SC; Arnett KL; Bernstein BE; Kieff E; Aster JC
Proc Natl Acad Sci U S A; 2011 Sep; 108(36):14908-13. PubMed ID: 21737748
[TBL] [Abstract][Full Text] [Related]
11. The NOTCH1-MYC highway toward T-cell acute lymphoblastic leukemia.
Sanchez-Martin M; Ferrando A
Blood; 2017 Mar; 129(9):1124-1133. PubMed ID: 28115368
[TBL] [Abstract][Full Text] [Related]
12. Tcf1 is essential for initiation of oncogenic Notch1-driven chromatin topology in T-ALL.
Antoszewski M; Fournier N; Ruiz Buendía GA; Lourenco J; Liu Y; Sugrue T; Dubey C; Nkosi M; Pritchard CEJ; Huijbers IJ; Segat GC; Alonso-Moreno S; Serracanta E; Belver L; Ferrando AA; Ciriello G; Weng AP; Koch U; Radtke F
Blood; 2022 Apr; 139(16):2483-2498. PubMed ID: 35020836
[TBL] [Abstract][Full Text] [Related]
13. Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation.
Shi J; Whyte WA; Zepeda-Mendoza CJ; Milazzo JP; Shen C; Roe JS; Minder JL; Mercan F; Wang E; Eckersley-Maslin MA; Campbell AE; Kawaoka S; Shareef S; Zhu Z; Kendall J; Muhar M; Haslinger C; Yu M; Roeder RG; Wigler MH; Blobel GA; Zuber J; Spector DL; Young RA; Vakoc CR
Genes Dev; 2013 Dec; 27(24):2648-62. PubMed ID: 24285714
[TBL] [Abstract][Full Text] [Related]
14.
Zimmerman MW; Liu Y; He S; Durbin AD; Abraham BJ; Easton J; Shao Y; Xu B; Zhu S; Zhang X; Li Z; Weichert-Leahey N; Young RA; Zhang J; Look AT
Cancer Discov; 2018 Mar; 8(3):320-335. PubMed ID: 29284669
[TBL] [Abstract][Full Text] [Related]
15. NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth.
Palomero T; Lim WK; Odom DT; Sulis ML; Real PJ; Margolin A; Barnes KC; O'Neil J; Neuberg D; Weng AP; Aster JC; Sigaux F; Soulier J; Look AT; Young RA; Califano A; Ferrando AA
Proc Natl Acad Sci U S A; 2006 Nov; 103(48):18261-6. PubMed ID: 17114293
[TBL] [Abstract][Full Text] [Related]
16. β-Catenin is required for T-cell leukemia initiation and MYC transcription downstream of Notch1.
Gekas C; D'Altri T; Aligué R; González J; Espinosa L; Bigas A
Leukemia; 2016 Oct; 30(10):2002-2010. PubMed ID: 27125305
[TBL] [Abstract][Full Text] [Related]
17. The common oncogenomic program of NOTCH1 and NOTCH3 signaling in T-cell acute lymphoblastic leukemia.
Choi SH; Severson E; Pear WS; Liu XS; Aster JC; Blacklow SC
PLoS One; 2017; 12(10):e0185762. PubMed ID: 29023469
[TBL] [Abstract][Full Text] [Related]
18. Cooperative action of multiple cis-acting elements is required for N-myc expression in branchial arches: specific contribution of GATA3.
Potvin E; Beuret L; Cadrin-Girard JF; Carter M; Roy S; Tremblay M; Charron J
Mol Cell Biol; 2010 Nov; 30(22):5348-63. PubMed ID: 20855530
[TBL] [Abstract][Full Text] [Related]
19. DEPTOR is a direct NOTCH1 target that promotes cell proliferation and survival in T-cell leukemia.
Hu Y; Su H; Liu C; Wang Z; Huang L; Wang Q; Liu S; Chen S; Zhou J; Li P; Chen Z; Liu H; Qing G
Oncogene; 2017 Feb; 36(8):1038-1047. PubMed ID: 27593934
[TBL] [Abstract][Full Text] [Related]
20. GATA3 acts upstream of FOXA1 in mediating ESR1 binding by shaping enhancer accessibility.
Theodorou V; Stark R; Menon S; Carroll JS
Genome Res; 2013 Jan; 23(1):12-22. PubMed ID: 23172872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
